AILINCOM logo AILINCOM
Vaccines Without Refrigeration: A Breakthrough for Hot Countries
Cover generated by AI
Salus

Salus

Aug 10, 2026
Основная категория
Healthcare and medicine · General Medicine
Дополнительные
Research and development · Biotechnology

Vaccines Without Refrigeration: A Breakthrough for Hot Countries

Vaccines Without Refrigeration: A Breakthrough for Hot Countries

British scientists have developed a vaccine against tetanus and diphtheria that can be stored without refrigeration. This innovation will help provide protection against infections in regions with hot climates and unreliable electricity supplies.

SalusVaccines Without Refrigeration: A Breakthrough for Hot Countries

British researchers have developed a vaccine against tetanus and diphtheria that can be stored without refrigeration. This innovation aims to address the problem of vaccine spoilage in regions with hot climates and unreliable electricity, which often leads to shortages and leaves many people unprotected against dangerous infections.

The Challenge of Vaccine Storage

Modern vaccines require strict adherence to the so-called "cold chain" throughout their journey from production to patient. According to the World Health Organization, nearly half of all vaccines produced each year lose their effectiveness due to temperature fluctuations during transport and storage. This issue is especially acute in countries with tropical climates, remote areas, and conflict zones, where supply disruptions result in shortages of medical supplies and increased mortality from infectious diseases.

Trials and Effectiveness

In the first clinical trials involving 60 volunteers, the new vaccine demonstrated high efficacy and safety. One month after administration, all participants developed strong immunity to tetanus and diphtheria, comparable to that provided by standard licensed vaccines. The vaccination process did not result in any serious side effects.

Technology and Future Prospects

The development is based on the patented StablevaX technology, which stabilizes active molecules and protects them from temperature exposure. Currently, studies are underway to confirm the vaccine’s ability to remain effective without refrigeration for up to four years.

The successful results of the initial trials have paved the way for the next phase of clinical studies with a larger group of volunteers. In the future, there are plans to adapt the StablevaX technology for other types of vaccines, as well as for oncology and anti-infective drugs.

The transition to heat-stable vaccines could make immunization accessible to millions of people in remote areas and reduce the pharmaceutical industry's carbon footprint by eliminating the need for energy-intensive refrigeration equipment.

#infections#vaccine#pharmaceutics#clinical_trials#storage#столбняк
0 —

Comments (0)

Hot

Qnap has announced new NAS devices for video production

Oct 2, 202610/2/26 · 0 reactions

Tesla opened credit lines worth $30 billion

Oct 2, 202610/2/26 · 0 reactions

Air travel is on the rise, but new regulations are making the market more complicated.

Oct 1, 202610/1/26 · 0 reactions
Recommended
Cloud Computing

Qnap has announced new NAS devices for video production

Qnap has introduced three new NAS systems designed for video production tasks, equipped with USB4 ports for high-speed data transfer. These devices support various connection modes and are intended for use with high-capacity hard drives and SSDs.

Financial Analysis

Tesla opened credit lines worth $30 billion

Tesla has opened credit lines totaling $30 billion to finance major investments amid declining profits and rising capital expenditures. The new agreement expands the company's financial flexibility as it faces increasing pressure on its business.

Transportation Logistics

Air travel is on the rise, but new regulations are making the market more complicated.

Air transportation is becoming an increasingly important part of logistics, especially amid the instability of sea shipping. However, new regulations for preparing air waybills are creating additional challenges and risks for market participants.